Price T Rowe Associates Inc Ocular Therapeutix, Inc Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 977,396 shares of OCUL stock, worth $8.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
977,396
Previous 1,110,454 11.98%
Holding current value
$8.31 Million
Previous $7.6 Million 11.94%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$6.45 - $9.23 $858,224 - $1.23 Million
-133,058 Reduced 11.98%
977,396 $8.5 Million
Q2 2024

Aug 14, 2024
BUY
$4.2 - $8.69 $1.88 Million - $3.89 Million
447,782 Added 67.57%
1,110,454 $7.6 Million
Q1 2024

May 15, 2024
BUY
$3.85 - $10.93 $2.35 Million - $6.66 Million
609,328 Added 1142.26%
662,672 $6.03 Million
Q4 2023

Feb 14, 2024
BUY
$2.08 - $4.52 $26,746 - $58,122
12,859 Added 31.76%
53,344 $238,000
Q3 2023

Nov 14, 2023
BUY
$3.14 - $5.04 $5,796 - $9,303
1,846 Added 4.78%
40,485 $128,000
Q2 2023

Aug 14, 2023
BUY
$4.6 - $7.64 $1,582 - $2,628
344 Added 0.9%
38,639 $200,000
Q1 2023

May 15, 2023
SELL
$2.79 - $6.27 $9,949 - $22,358
-3,566 Reduced 8.52%
38,295 $202,000
Q4 2022

Feb 14, 2023
BUY
$2.61 - $4.41 $28,636 - $48,386
10,972 Added 35.52%
41,861 $118,000
Q3 2022

Nov 14, 2022
BUY
$4.09 - $6.5 $20,372 - $32,376
4,981 Added 19.23%
30,889 $129,000
Q2 2022

Aug 15, 2022
BUY
$3.01 - $5.22 $18,562 - $32,191
6,167 Added 31.24%
25,908 $104,000
Q1 2022

May 16, 2022
BUY
$4.83 - $7.35 $31,303 - $47,635
6,481 Added 48.88%
19,741 $98,000
Q4 2021

Feb 14, 2022
SELL
$6.16 - $12.07 $131,208 - $257,091
-21,300 Reduced 61.63%
13,260 $92,000
Q3 2021

Nov 15, 2021
SELL
$9.7 - $14.34 $969 - $1,434
-100 Reduced 0.29%
34,560 $346,000
Q2 2021

Aug 16, 2021
BUY
$13.43 - $19.16 $23,623 - $33,702
1,759 Added 5.35%
34,660 $491,000
Q1 2021

May 17, 2021
BUY
$15.82 - $22.11 $110,312 - $154,173
6,973 Added 26.89%
32,901 $540,000
Q4 2020

Feb 16, 2021
BUY
$7.91 - $22.95 $205,090 - $595,047
25,928 New
25,928 $537,000

Others Institutions Holding OCUL

# of Institutions
171
Shares Held
138M
Call Options Held
150K
Put Options Held
225K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $654M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email